Current and emerging pharmacological targets and treatments of urinary incontinence and related disorders

MC Michel, L Cardozo, CJ Chermansky, F Cruz… - Pharmacological …, 2023 - ASPET
Overactive bladder syndrome with and without urinary incontinence and related conditions,
signs, and disorders such as detrusor overactivity, neurogenic lower urinary tract …

Urinary incontinence—pharmacotherapy options

AL Smith, AJ Wein - Annals of medicine, 2011 - Taylor & Francis
The impact of incontinence is felt by millions of people worldwide, with tremendous
decrement in quality of life and enormous cost reaching billions of dollars. Urinary …

Pharmacological agents for the treatment of urinary incontinence due to overactive bladder

AJ Wein - Expert Opinion on Investigational Drugs, 2001 - Taylor & Francis
Although the exact aetiology of overactive bladder is unknown to date, pharmacological
therapy has been targeted to both the central and peripheral nervous systems. Potential …

Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence

KE Andersson, AJ Wein - Pharmacological reviews, 2004 - ASPET
The lower urinary tract constitutes a functional unit controlled by a complex interplay
between the central and peripheral nervous systems and local regulatory factors. In the …

Current pharmacotherapeutic strategies for overactive bladder

LJ Burrows, AD Garely - Expert Opinion on Pharmacotherapy, 2002 - Taylor & Francis
Overactive bladder (OAB) is a chronic, distressing condition characterised by symptoms of
urgency (sudden overwhelming urge to urinate) and frequency (urinating more than eight …

Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence

KE Andersson, CR Chapple, L Cardozo… - Current opinion in …, 2009 - journals.lww.com
Pharmacological treatment of overactive bladder: report from... : Current Opinion in Urology
Pharmacological treatment of overactive bladder: report from the International Consultation on …

Current and emerging investigational medical therapies for the treatment of overactive bladder

A Tiwari, KS Naruganahalli - Expert Opinion on Investigational …, 2006 - Taylor & Francis
Overactive bladder (OAB) is a chronic distressing condition characterised by urinary urgency
with or without urge incontinence, usually with frequency (voiding at least eight times daily) …

[HTML][HTML] Management of urinary incontinence

GA DeMaagd, TC Davenport - Pharmacy and Therapeutics, 2012 - ncbi.nlm.nih.gov
Accepted for publication January 23, 2012. cerebrovascular disease, diabetes,
hypertension, obstructive sleep apnea, and normal-pressure hydrocephalus. Functional …

Drug therapy of urinary urge incontinence: a systematic review

G Haeusler, H Leitich, M van Trotsenburg… - Obstetrics & …, 2002 - Elsevier
OBJECTIVE: To review the efficacy of drug therapy for urinary urge incontinence by
examining the published literature. METHODS OF STUDY SELECTION: In October 1999, we …

Urinary incontinence: economic burden and new choices in pharmaceutical treatment

R Levy, N Muller - Advances in therapy, 2006 - Springer
In the year 2000, an estimated 17 million community-dwelling adults in the United States
had daily urinary incontinence (UI), and an additional 33 million suffered from the …